摘要
目的:比较吗氯贝胺(MCL)与阿米替林(AML)治疗躯体化障碍的疗效及不良反应。方法:将60例符号CCMD-3诊断标准的躯体障碍神经症患者,随机分为应用MCL(30例)或MAL(30例)治疗6周,采用Hamilton焦虑量表(HAMA)和副作用反应量表(TESS)评定疗效及不良反应。结果:MCL与AML对躯体化障碍均有疗效,两组间无显著性差异(P>0.05)。MCL副反应明显少于AML(P<0.01)。结论:MCI治疗躯体化障碍疗效确切,副作用少而轻,患者服药依从性好。
Objectiv: To compave the efficacy and side effects of moclobemicle (MCL) and amitriptyine (AML) in tredtment of somatization disorder. Methods: 60 patients who met with the criteria of CCMD- 3 for somatization disorders were randomly assigned to MCL and AML treatment for 6weeke. Efficacy and side effects were evaluated with Hamilton Anxiety Scale ( HAMA) and Treatment Emergent Symptoms Scale (TESS). Re-ssults: Both drugs, had marked efficacy in treatment of somatization disorer, MCL had fewer side effects than AML. Conclusion: I tis suggested that MCL wes effective in the treatment of somatization disorer and produced fewer side effiects.
出处
《中国民康医学》
2004年第3期148-148,159,共2页
Medical Journal of Chinese People’s Health
